• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人种间人血小板 PAR4 反应性的差异反映了 PCTP 和 miR-376c 的表达。

Racial differences in human platelet PAR4 reactivity reflect expression of PCTP and miR-376c.

机构信息

The Cardeza Foundation for Hematologic Research and Department of Medicine, Jefferson Medical College, Thomas Jefferson University, Philadelphia, Pennsylvania, USA.

出版信息

Nat Med. 2013 Dec;19(12):1609-16. doi: 10.1038/nm.3385. Epub 2013 Nov 10.

DOI:10.1038/nm.3385
PMID:24216752
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3855898/
Abstract

Racial differences in the pathophysiology of atherothrombosis are poorly understood. We explored the function and transcriptome of platelets in healthy black (n = 70) and white (n = 84) subjects. Platelet aggregation and calcium mobilization induced by the PAR4 thrombin receptor were significantly greater in black subjects. Numerous differentially expressed RNAs were associated with both race and PAR4 reactivity, including PCTP (encoding phosphatidylcholine transfer protein), and platelets from black subjects expressed higher levels of PC-TP protein. PC-TP inhibition or depletion blocked PAR4- but not PAR1-mediated activation of platelets and megakaryocytic cell lines. miR-376c levels were differentially expressed by race and PAR4 reactivity and were inversely correlated with PCTP mRNA levels, PC-TP protein levels and PAR4 reactivity. miR-376c regulated the expression of PC-TP in human megakaryocytes. A disproportionately high number of microRNAs that were differentially expressed by race and PAR4 reactivity, including miR-376c, are encoded in the DLK1-DIO3 locus and were expressed at lower levels in platelets from black subjects. These results suggest that PC-TP contributes to the racial difference in PAR4-mediated platelet activation, indicate a genomic contribution to platelet function that differs by race and emphasize a need to consider the effects of race when developing anti-thrombotic drugs.

摘要

种族间动脉粥样血栓形成的病理生理学差异尚未被充分了解。我们研究了健康的黑种人(n=70)和白种人(n=84)血小板的功能和转录组。PAR4 凝血酶受体诱导的血小板聚集和钙动员在黑种人中显著增加。许多差异表达的 RNA 与种族和 PAR4 反应性相关,包括 PCTP(编码磷脂酰胆碱转移蛋白),并且黑种人的血小板表达更高水平的 PC-TP 蛋白。PC-TP 抑制或耗竭可阻断 PAR4 而非 PAR1 介导的血小板和巨核细胞系的激活。miR-376c 的表达水平因种族和 PAR4 反应性而异,与 PCTP mRNA 水平、PC-TP 蛋白水平和 PAR4 反应性呈负相关。miR-376c 调节人类巨核细胞中 PC-TP 的表达。有相当数量的 microRNAs 因种族和 PAR4 反应性而差异表达,包括 miR-376c,这些 microRNAs 编码在 DLK1-DIO3 基因座中,并且在黑种人的血小板中表达水平较低。这些结果表明,PC-TP 有助于 PAR4 介导的血小板激活中的种族差异,表明血小板功能的基因组贡献因种族而异,并强调在开发抗血栓药物时需要考虑种族的影响。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0bca/3855898/7f191bc0d027/nihms526482f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0bca/3855898/78dddcf432af/nihms526482f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0bca/3855898/044656ab721f/nihms526482f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0bca/3855898/8ba3191d7591/nihms526482f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0bca/3855898/a29c56b3267f/nihms526482f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0bca/3855898/7f191bc0d027/nihms526482f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0bca/3855898/78dddcf432af/nihms526482f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0bca/3855898/044656ab721f/nihms526482f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0bca/3855898/8ba3191d7591/nihms526482f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0bca/3855898/a29c56b3267f/nihms526482f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0bca/3855898/7f191bc0d027/nihms526482f5.jpg

相似文献

1
Racial differences in human platelet PAR4 reactivity reflect expression of PCTP and miR-376c.人种间人血小板 PAR4 反应性的差异反映了 PCTP 和 miR-376c 的表达。
Nat Med. 2013 Dec;19(12):1609-16. doi: 10.1038/nm.3385. Epub 2013 Nov 10.
2
Common variants in the human platelet PAR4 thrombin receptor alter platelet function and differ by race.人类血小板PAR4凝血酶受体中的常见变异会改变血小板功能,且存在种族差异。
Blood. 2014 Nov 27;124(23):3450-8. doi: 10.1182/blood-2014-04-572479. Epub 2014 Oct 7.
3
Protease-activated receptor-4 (PAR4) variant influences on platelet reactivity induced by PAR4-activating peptide through altered Ca mobilization and ERK phosphorylation in healthy Japanese subjects.健康的日本受试者中,蛋白酶激活受体 4(PAR4)变体通过改变 Ca2+动员和 ERK 磷酸化来影响 PAR4 激活肽诱导的血小板反应性。
Thromb Res. 2018 Feb;162:44-52. doi: 10.1016/j.thromres.2017.12.014. Epub 2017 Dec 24.
4
Identification of a functional genetic variant driving racially dimorphic platelet gene expression of the thrombin receptor regulator, PCTP.一种功能性基因变异的鉴定,该变异驱动凝血酶受体调节剂PCTP的种族双态性血小板基因表达。
Thromb Haemost. 2017 May 3;117(5):962-970. doi: 10.1160/TH16-09-0692. Epub 2017 Mar 2.
5
PCTP contributes to human platelet activation by enhancing dense granule secretion.PCTP 通过增强致密颗粒分泌促进人血小板活化。
Thromb Res. 2021 Jun;202:67-73. doi: 10.1016/j.thromres.2021.03.003. Epub 2021 Mar 8.
6
Biphasic kinetics of activation and signaling for PAR1 and PAR4 thrombin receptors in platelets.血小板中PAR1和PAR4凝血酶受体激活及信号传导的双相动力学
Biochemistry. 2000 May 9;39(18):5458-67. doi: 10.1021/bi9927078.
7
Protease-activated receptors 1 and 4 mediate activation of human platelets by thrombin.蛋白酶激活受体1和4介导凝血酶对人血小板的激活作用。
J Clin Invest. 1999 Mar;103(6):879-87. doi: 10.1172/JCI6042.
8
The ATP-gated P2X1 receptor plays a pivotal role in activation of aspirin-treated platelets by thrombin and epinephrine.三磷酸腺苷(ATP)门控的P2X1受体在凝血酶和肾上腺素激活经阿司匹林处理的血小板过程中起关键作用。
J Biol Chem. 2008 Jul 4;283(27):18493-504. doi: 10.1074/jbc.M800358200. Epub 2008 May 14.
9
Mechanism of race-dependent platelet activation through the protease-activated receptor-4 and Gq signaling axis.通过蛋白酶激活受体-4和Gq信号轴的种族依赖性血小板激活机制。
Arterioscler Thromb Vasc Biol. 2014 Dec;34(12):2644-50. doi: 10.1161/ATVBAHA.114.304249. Epub 2014 Oct 2.
10
Platelet protease-activated receptor (PAR)4, but not PAR1, associated with neutral sphingomyelinase responsible for thrombin-stimulated ceramide-NF-κB signaling in human platelets.血小板蛋白酶激活受体 (PAR)4,但不是 PAR1,与中性鞘磷脂酶相关,该酶负责凝血酶刺激的人血小板神经酰胺-NF-κB 信号转导。
Haematologica. 2013 May;98(5):793-801. doi: 10.3324/haematol.2012.072553. Epub 2012 Oct 12.

引用本文的文献

1
Humanized murine models of platelet function.血小板功能的人源化小鼠模型。
Curr Opin Hematol. 2025 Jul 14. doi: 10.1097/MOH.0000000000000879.
2
Post-COVID Mucormycosis-Conceptual Etiology and New Treatment Options.新冠后毛霉菌病——概念性病因及新的治疗选择
J Maxillofac Oral Surg. 2024 Dec;23(6):1516-1527. doi: 10.1007/s12663-024-02124-5. Epub 2024 May 16.
3
Observational Analyses of Ex Vivo Native American Platelet Responses.体外观察分析美洲原住民血小板反应。

本文引用的文献

1
Mechanisms of acute coronary syndromes and their implications for therapy.急性冠状动脉综合征的机制及其对治疗的意义。
N Engl J Med. 2013 May 23;368(21):2004-13. doi: 10.1056/NEJMra1216063.
2
Vorapaxar in patients with peripheral artery disease: results from TRA2{degrees}P-TIMI 50.外周动脉疾病患者应用Vorapaxar:TRA2°P-TIMI 50 研究结果。
Circulation. 2013 Apr 9;127(14):1522-9, 1529e1-6. doi: 10.1161/CIRCULATIONAHA.112.000679. Epub 2013 Mar 15.
3
Vorapaxar for secondary prevention of thrombotic events for patients with previous myocardial infarction: a prespecified subgroup analysis of the TRA 2°P-TIMI 50 trial.
Int J Mol Sci. 2024 Nov 8;25(22):11990. doi: 10.3390/ijms252211990.
4
Expression quantitative trait locus mapping of extracellular microRNAs in human plasma.人血浆中细胞外微小RNA的表达数量性状基因座定位
iScience. 2024 Sep 18;27(10):110988. doi: 10.1016/j.isci.2024.110988. eCollection 2024 Oct 18.
5
A Platelet Reactivity ExpreSsion Score derived from patients with peripheral artery disease predicts cardiovascular risk.外周动脉疾病患者的血小板反应性表达评分可预测心血管风险。
Nat Commun. 2024 Aug 20;15(1):6902. doi: 10.1038/s41467-024-50994-7.
6
Ethnic Disparities in the Risk Factors, Morbidity, and Mortality of Cardiovascular Disease in People With Diabetes.糖尿病患者心血管疾病风险因素、发病率及死亡率的种族差异
J Endocr Soc. 2024 Jun 12;8(7):bvae116. doi: 10.1210/jendso/bvae116. eCollection 2024 May 23.
7
Heterogeneity of platelets and their responses.血小板的异质性及其反应。
Res Pract Thromb Haemost. 2024 Mar 1;8(2):102356. doi: 10.1016/j.rpth.2024.102356. eCollection 2024 Feb.
8
Liquid biopsy techniques and lung cancer: diagnosis, monitoring and evaluation.液体活检技术与肺癌:诊断、监测与评估。
J Exp Clin Cancer Res. 2024 Apr 1;43(1):96. doi: 10.1186/s13046-024-03026-7.
9
Immunothrombosis versus thrombo-inflammation: platelets in cerebrovascular complications.免疫血栓形成与血栓炎症:脑血管并发症中的血小板
Res Pract Thromb Haemost. 2024 Feb 9;8(1):102344. doi: 10.1016/j.rpth.2024.102344. eCollection 2024 Jan.
10
Antiplatelet strategies: past, present, and future.抗血小板策略:过去、现在和未来。
J Thromb Haemost. 2023 Dec;21(12):3317-3328. doi: 10.1016/j.jtha.2023.09.013.
Vorapaxar 用于预防既往心肌梗死患者的血栓事件复发:TRA 2°P-TIMI 50 试验的预先设定亚组分析。
Lancet. 2012 Oct 13;380(9850):1317-24. doi: 10.1016/S0140-6736(12)61269-0. Epub 2012 Aug 26.
4
The Akt1 isoform is required for optimal IFN-β transcription through direct phosphorylation of β-catenin.Akt1 同工型通过直接磷酸化β-连环蛋白(β-catenin)来促进 IFN-β 转录。
J Immunol. 2012 Sep 15;189(6):3104-11. doi: 10.4049/jimmunol.1201669. Epub 2012 Aug 17.
5
Alteration of the platelet transcriptome in chronic kidney disease.慢性肾脏病中血小板转录组的改变。
Thromb Haemost. 2012 Oct;108(4):605-15. doi: 10.1160/TH12-03-0153. Epub 2012 Jul 26.
6
The microRNAs within the DLK1-DIO3 genomic region: involvement in disease pathogenesis.DLK1-DIO3 基因组区域内的 microRNAs:在疾病发病机制中的作用。
Cell Mol Life Sci. 2013 Mar;70(5):795-814. doi: 10.1007/s00018-012-1080-8. Epub 2012 Jul 24.
7
The down-regulation of miR-125b in chronic lymphocytic leukemias leads to metabolic adaptation of cells to a transformed state.慢性淋巴细胞白血病中 miR-125b 的下调导致细胞向转化状态的代谢适应。
Blood. 2012 Sep 27;120(13):2631-8. doi: 10.1182/blood-2012-03-415737. Epub 2012 Jun 21.
8
Vorapaxar in the secondary prevention of atherothrombotic events.沃拉帕沙用于动脉粥样血栓事件的二级预防。
N Engl J Med. 2012 Apr 12;366(15):1404-13. doi: 10.1056/NEJMoa1200933. Epub 2012 Mar 24.
9
Lifetime risks of cardiovascular disease.心血管疾病的终身风险。
N Engl J Med. 2012 Jan 26;366(4):321-9. doi: 10.1056/NEJMoa1012848.
10
Protein kinase C regulation of 12-lipoxygenase-mediated human platelet activation.蛋白激酶 C 对 12-脂氧合酶介导的人血小板激活的调节作用。
Mol Pharmacol. 2012 Mar;81(3):420-30. doi: 10.1124/mol.111.075630. Epub 2011 Dec 9.